Skip links

Viltepso® (viltolarsen)

Full Name Viltepso® (viltolarsen)
Drug Viltepso
Manufacturer NS Pharma
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology
Enrollment Form Link Viltepso Enrollment Form
Phone Number 800-759-0445
Fax Number 877-286-3620
Product Website